
|
Medicademy Module R5: Regulatory Strategic Considerations during Global Drug Development
|
|
 |
Registration deadline: 5 September 2013 Exam:Date of examination: November 4, 2013 You can tak the exam in your own country! Medicademy arrange examinations at Embassies, Universities etc. all over the world. Information about examination form etc. will follow.
|
 |
Register:
|
|

Startdate: 3 October 2013 - 4 October 2013 Purpose: Pharmaceutical industries and small start-up biotechnology companies are under heavy pressure to develop new and effective drugs, and at the same time meet the financial expectations. In order to meet these expectations, including a faster and more efficient drug development, regulatory affairs experts must take an active and crucial part in the entire development process.
Regulatory courses normally focus on laws, guidelines, and directives, but offer little knowledge on the role of regulatory experts in project teams. Consequently, this module will not focus on guidelines, but look behind them, and provide the students with knowledge of the background and thinking behind the key factors of global regulatory strategies and the preceding considerations. The course offers a number of internationally experienced lecturers, who will guide the students through important key issues such as:
• Regulatory Affairs Involvement in Product Development • Regulatory Strategies • Consultation with Authorities throughout Development • Regulatory Intelligence • The Development of a Target Label • Regulatory Planning in the Submission Step • Intellectual Property Rights - Data Exclusivity • Pricing and Reimbursement Negotiations
At this module you will really get behind regulatory decisions and strategies. Everyone working within the Regulatory Affairs Area knows how important and how much more effective you will be able to work if you have an in-depth understanding and knowledge of how and why they are made. Every regulatory affairs employee will be able to benefit from this knowledge and take an active and more efficient part in future decision-making processes.
By the end of this module, the student should be able to:
- understand the purpose of and processes in developing a regulatory strategy for products in various stages of the product life cycle
- analyse strengths and weaknesses of a product in order to develop regulatory strategies and target product profiles
- use best practice, when communicating a regulatory strategy to the company project team or top management, and to operate in a highly dynamic and constantly changing environment, where internal as well as external business partners and authorities need to understand the rationale of the product development Content:Areas that among others will be covered in this two-day intensive course are: - Introduction to Regulatory Strategy
- Regulatory Strategies and Strategic Considerations in General
- Regulatory Strategies and Strategic Considerations in the USA
- Regulatory Intelligence
- Regulatory Strategies and Strategic Considerations in the EU
- Life Cycle Management Strategies
- Regulatory Strategy Plan – case story
- Regulatory Strategies and Strategic Considerations in Japan
- Exclusivity
- Target Labelling – Key Elements, Sources of Information and the Studies
- The Concept of Target Labeling for a New Molecular Entity
- The Studies Supporting the Target Labeling
- Pharmacoeconomics
Course Leaders:
Vice President, Regulatory Affairs, Genmab A/S, Denmark Ann Christine Korsgaard Senior Regulatory Affairs Manager, AstraZeneca A/S, Nordic Helen Maria Shennan Lecturers in 2012 - we expect to be able to employ the same lecturers in 2013: Vice President Regulatory Affairs, Orexo AB, Sweden Åsa Holmgren Director Regulatory Affairs and Compliance, Xoma, USA Cheryl Madsen Head Regulatory Affairs Products, Leo Pharma A/S, Denmark Helle Langgaard
European Regulatory Portfolio Leader Oncology / Infection, AstraZeneca, Belgium Anne de Bock Vice President, Regulatory Affairs, Genmab A/S, Denmark Ann Christine Korsgaard
Associate Director, Novo Nordisk A/S, Denmark Torsten Christensen
Senior Regulatory Affairs Manager AstraZeneca, Nordic Helen Maria Shennan
More international lecturers will be added... Prerequisites:In order to secure the professional level of the education. The participants must have a educational background at bachelor level within a relevant area and at least two years’ experience within Regulatory Affairs or equivalent qualifications. Please note that applications will be considered in order of receipt. Medicademy accept up to 10 - 20 % of the seats at a module to be occupied by applicants who have none or limited experience within the regulatory affairs area. These participants must have experience within the pharmaceutical/biological area that qualify them to benefit from the training and to participate actively during the module. The participation will be considered on a case-by-case basis. Literature:A list of recommended literature will be send to the participants approx. 4 weeks prior to the start of the module. The list will be divided into mandatory and optional reading. The mandatory references is part of the examination syllabus. The participants are expected to study and be familiar with the mandatory references in advance of the module. Accomodation (not included in the course fee):
If you need hotel accommodation, we recommend Hotel Twentyseven where you will get a discounted price, but you are of course welcome to choose any other hotel that you might prefer, but the shuttle bus will go from Hotel Twentyseven to Medicademy in the morning and from Medicademy to Hotel Twentyseven in the afternoon. There are no hotels very close to the Medicademy facilities which is why we have chosen this hotel, very centrally located, situated in downtown Copenhagen and close to the central train station of Copenhagen (Københavns Hovedbanegård), to where the airport train goes. We have fixed prices at this hotel, which means that you are guaranteed to get the prices below. However, if the prices at some days/periods are lowered – you will of course get the lower price! Do always check the price of the day you stay there! Hotel Twentyseven
Hotel Twentyseven is located in the heart of Copenhagen, close to the Town Hall Square, the Tivoli Gardens, and Copenhagen Central Station, and airport trains, S-trains, regional trains, and busses leave from the station regularly. Hotel Twentyseven has a special atmosphere based on unique experiences, living design, seductive comfort, hospitality, and an uncomplicated life. All the 200 rooms in the hotel have been designed in the well-known Scandinavian design tradition by leading Danish designers & architects. www.hotel27.dk
Fixed prices – breakfast included: Small single room - DKK 930 (approx. EUR 125), Double room for 1 person – DKK 1,080 (approx. EUR 145) Shuttle Bus - Included in the Course Fee!
Medicademy arrange transportation by bus every day from Hotel Twentyseven in the morning to Medicademy and back again in the evening from Medicademy to Hotel Twentyseven – included in the course fee! Networking Dinner - Included in the Course Fee!
The networking dinner takes place at Hotel Twentyseven on the first night of the module - October 3, 2013! |

 |
Plads til diskussion – rigtig godt
Ann-Lisbeth Aarup Nielsen - ALK-Albelló - Regulatory Affairs Officer
|
 |
|
|
|
Tina Jensen
Tina Jensen is Program Director, Medicademy Regulatory Affairs and responsible for Introduction to Drug Registration.
|
|
|
Lif Education, Diploma in Basic Pharmaceutical Medicine, Clinical Research, Drug Development, Medicademy Pharmacovigilance, Medicademy Regulatory Affairs, RA, PV, Pharmacovigilance, Regulatory Affairs
|
|
|